首页 > 最新文献

The primary care companion for CNS disorders最新文献

英文 中文
Hallucinations Following Intravenous Use of Tapentadol 静脉注射他喷他多后出现幻觉
Q4 Medicine Pub Date : 2024-07-23 DOI: 10.4088/pcc.24cr03722
Gaurav Kumar Singh, Abhishek Khatri, Ateev Sudhir Chandna, Lekhansh Shukla, J. Mahadevan
{"title":"Hallucinations Following Intravenous Use of Tapentadol","authors":"Gaurav Kumar Singh, Abhishek Khatri, Ateev Sudhir Chandna, Lekhansh Shukla, J. Mahadevan","doi":"10.4088/pcc.24cr03722","DOIUrl":"https://doi.org/10.4088/pcc.24cr03722","url":null,"abstract":"","PeriodicalId":22814,"journal":{"name":"The primary care companion for CNS disorders","volume":"114 4","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-07-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141812013","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Psychiatric History of Presenting Illness Mnemonic. 现症精神病史记忆法。
Q4 Medicine Pub Date : 2024-07-18 DOI: 10.4088/PCC.23lr03699
Abdulsamad A Aljeshi
{"title":"Psychiatric History of Presenting Illness Mnemonic.","authors":"Abdulsamad A Aljeshi","doi":"10.4088/PCC.23lr03699","DOIUrl":"https://doi.org/10.4088/PCC.23lr03699","url":null,"abstract":"","PeriodicalId":22814,"journal":{"name":"The primary care companion for CNS disorders","volume":"26 4","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-07-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141752911","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mild Cognitive Impairment: Clinical Presentation and Short-Term Comparative Outcome of Patients With Potentially Modifiable and Nonmodifiable Risk Factors. 轻度认知障碍:临床表现以及具有潜在可改变和不可改变风险因素的患者的短期疗效比较。
Q4 Medicine Pub Date : 2024-07-18 DOI: 10.4088/PCC.24m03708
Kavita Moria, Arvind Sharma, Pir Dutt Bansal, Mamta Bahetra, Bhavneesh Saini, Priyanka Bansal, Vanipreet Kaur, Gurpreet Singh, Jaskaran Singh, Harshdeep Kaur

Objective: To estimate the prevalence and study the clinical presentation of mild cognitive impairment (MCI), assess its outcome in terms of cognition and quality of life, identify factors for reversion to baseline, and compare these factors in the modifiable and nonmodifiable risk factor groups.

Methods: Individuals aged >50 years with memory/cognitive complaint(s) were screened using the Mini-Cog over 1 year (August 2018-August 2019). Those meeting the DSM-5 criteria for MCI were enrolled, and risk factors (modifiable and nonmodifiable) were noted. Assessments were done using the Hindi version of the Montreal Cognitive Assessment (H-MoCA), the Clinical Dementia Rating (CDR)-Hindi version, and the World Health Organization Quality of Life-Brief Hindi version. Treatment outcome was assessed at 6 months and compared between the risk factor groups. Factors for reversion of MCI were assessed.

Results: A total of 124 patients (22.1% of 561 with cognitive complaints) had MCI, and 100 patients (50 patients from the modifiable group and 50 patients from the nonmodifiable group) completed the study. Depression (52%) and hypertension (48%) were common risk factors. End point cognition scores were similar in both groups, with quality of life better in the modifiable group (P = .023). Age was negatively correlated with cognition in total patients and the nonmodifiable group (r =0.283-0.420; P = .002-.004). In total patients, cognition moderately correlated with education and somewhat with quality of life; 31% and 57% reverted to normal on the MoCA and CDR scales, respectively, while 1 progressed to dementia. Reverters had higher baseline H-MoCA scores (odds ratio [OR] = 6.996; P < .001) and were treated with cholinesterase inhibitors + vitamin E (OR = 28.999; P = .007).

Conclusion: Short-term outcome for both the modifiable and nonmodifiable risk factor groups was favorable. Higher education positively correlated with cognition, which itself predicted a better quality of life. Reverters of MCI had better baseline cognition and were treated with cholinesterase inhibitors + vitamin E.

Prim Care Companion CNS Disord 2024;26(4):24m03708.

Author affiliations are listed at the end of this article.

目的估算轻度认知障碍(MCI)的患病率并研究其临床表现,评估其在认知和生活质量方面的结果,确定恢复到基线的因素,并在可改变风险因素组和不可改变风险因素组中比较这些因素:在一年内(2018 年 8 月至 2019 年 8 月)使用 Mini-Cog 对年龄大于 50 岁、有记忆/认知症状的个体进行筛查。符合DSM-5标准的MCI患者被纳入其中,并记录了风险因素(可改变和不可改变)。评估采用印地语版蒙特利尔认知评估(H-MoCA)、印地语版临床痴呆评级(CDR)和世界卫生组织印地语版生活质量简表。治疗结果在 6 个月后进行评估,并在风险因素组之间进行比较。对MCI复发的因素进行了评估:共有 124 名患者(占 561 名认知症状患者的 22.1%)患有 MCI,其中 100 名患者(50 名来自可改变风险因素组,50 名来自不可改变风险因素组)完成了研究。抑郁症(52%)和高血压(48%)是常见的风险因素。两组患者的终点认知评分相似,可改变组患者的生活质量更高(P = .023)。在所有患者和不可改变病情组中,年龄与认知能力呈负相关(r =0.283-0.420; P = .002-.004)。在所有患者中,认知能力与教育程度呈中度相关,与生活质量呈一定程度的相关;MoCA和CDR量表中分别有31%和57%的患者恢复正常,而有1名患者发展为痴呆。恢复者的基线H-MoCA评分较高(几率比[OR] = 6.996;P < .001),并接受了胆碱酯酶抑制剂+维生素E治疗(OR = 28.999;P = .007):结论:可改变风险因素组和不可改变风险因素组的短期疗效都很好。高学历与认知能力呈正相关,而认知能力本身又预示着更好的生活质量。MCI逆转者的基线认知能力较好,并接受了胆碱酯酶抑制剂+维生素E的治疗.Prim Care Companion CNS Disord 2024;26(4):24m03708。 作者单位列于本文末尾。
{"title":"Mild Cognitive Impairment: Clinical Presentation and Short-Term Comparative Outcome of Patients With Potentially Modifiable and Nonmodifiable Risk Factors.","authors":"Kavita Moria, Arvind Sharma, Pir Dutt Bansal, Mamta Bahetra, Bhavneesh Saini, Priyanka Bansal, Vanipreet Kaur, Gurpreet Singh, Jaskaran Singh, Harshdeep Kaur","doi":"10.4088/PCC.24m03708","DOIUrl":"https://doi.org/10.4088/PCC.24m03708","url":null,"abstract":"<p><p><b>Objective:</b> To estimate the prevalence and study the clinical presentation of mild cognitive impairment (MCI), assess its outcome in terms of cognition and quality of life, identify factors for reversion to baseline, and compare these factors in the modifiable and nonmodifiable risk factor groups.</p><p><p><b>Methods:</b> Individuals aged >50 years with memory/cognitive complaint(s) were screened using the Mini-Cog over 1 year (August 2018-August 2019). Those meeting the <i>DSM-5</i> criteria for MCI were enrolled, and risk factors (modifiable and nonmodifiable) were noted. Assessments were done using the Hindi version of the Montreal Cognitive Assessment (H-MoCA), the Clinical Dementia Rating (CDR)-Hindi version, and the World Health Organization Quality of Life-Brief Hindi version. Treatment outcome was assessed at 6 months and compared between the risk factor groups. Factors for reversion of MCI were assessed.</p><p><p><b>Results:</b> A total of 124 patients (22.1% of 561 with cognitive complaints) had MCI, and 100 patients (50 patients from the modifiable group and 50 patients from the nonmodifiable group) completed the study. Depression (52%) and hypertension (48%) were common risk factors. End point cognition scores were similar in both groups, with quality of life better in the modifiable group (<i>P</i> = .023). Age was negatively correlated with cognition in total patients and the nonmodifiable group (<i>r</i> =0.283-0.420; <i>P</i> = .002-.004). In total patients, cognition moderately correlated with education and somewhat with quality of life; 31% and 57% reverted to normal on the MoCA and CDR scales, respectively, while 1 progressed to dementia. Reverters had higher baseline H-MoCA scores (odds ratio [OR] = 6.996; <i>P</i> < .001) and were treated with cholinesterase inhibitors + vitamin E (OR = 28.999; <i>P</i> = .007).</p><p><p><b>Conclusion:</b> Short-term outcome for both the modifiable and nonmodifiable risk factor groups was favorable. Higher education positively correlated with cognition, which itself predicted a better quality of life. Reverters of MCI had better baseline cognition and were treated with cholinesterase inhibitors + vitamin E.</p><p><p><i>Prim Care Companion CNS Disord 2024;26(4):24m03708</i>.</p><p><p>\u0000 <i>Author affiliations are listed at the end of this article.</i>\u0000 </p>","PeriodicalId":22814,"journal":{"name":"The primary care companion for CNS disorders","volume":"26 4","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-07-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141752910","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pharmacologic Management of the Sequelae of Traumatic Brain Injuries 脑外伤后遗症的药物治疗
Q4 Medicine Pub Date : 2024-07-16 DOI: 10.4088/pcc.23f03670
Sofia E Matta, Christina LaCroix, Kaloyan Tanev, Theodore A. Stern
{"title":"Pharmacologic Management of the Sequelae of Traumatic Brain Injuries","authors":"Sofia E Matta, Christina LaCroix, Kaloyan Tanev, Theodore A. Stern","doi":"10.4088/pcc.23f03670","DOIUrl":"https://doi.org/10.4088/pcc.23f03670","url":null,"abstract":"","PeriodicalId":22814,"journal":{"name":"The primary care companion for CNS disorders","volume":"2 6","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-07-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141640731","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clozapine-Related Cecal Volvulus. 氯氮平导致的盲肠溃疡
Q4 Medicine Pub Date : 2024-07-11 DOI: 10.4088/PCC.24cr03729
Sharlo L Bayless, Nathaniel V Walker, Maxwell M Scott, Raphael J Leo
{"title":"Clozapine-Related Cecal Volvulus.","authors":"Sharlo L Bayless, Nathaniel V Walker, Maxwell M Scott, Raphael J Leo","doi":"10.4088/PCC.24cr03729","DOIUrl":"10.4088/PCC.24cr03729","url":null,"abstract":"","PeriodicalId":22814,"journal":{"name":"The primary care companion for CNS disorders","volume":"26 4","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-07-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141601864","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
"I Don't Want to Live Like This Anymore": The Role of Psychiatry and Clinical Ethics in Withdrawing Life-Sustaining Treatment. "我不想再这样活下去了":精神病学和临床伦理在撤销维持生命治疗中的作用》。
Q4 Medicine Pub Date : 2024-07-09 DOI: 10.4088/PCC.24cr03715
Arlen Gaba, Sahil Munjal
{"title":"\"I Don't Want to Live Like This Anymore\": The Role of Psychiatry and Clinical Ethics in Withdrawing Life-Sustaining Treatment.","authors":"Arlen Gaba, Sahil Munjal","doi":"10.4088/PCC.24cr03715","DOIUrl":"10.4088/PCC.24cr03715","url":null,"abstract":"","PeriodicalId":22814,"journal":{"name":"The primary care companion for CNS disorders","volume":"26 4","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-07-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141601863","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Suicide Attempts in Gambling Disorder. 赌博障碍中的自杀企图。
Q4 Medicine Pub Date : 2024-07-04 DOI: 10.4088/PCC.24lr03719
Samuel R Chamberlain, Jon E Grant
{"title":"Suicide Attempts in Gambling Disorder.","authors":"Samuel R Chamberlain, Jon E Grant","doi":"10.4088/PCC.24lr03719","DOIUrl":"10.4088/PCC.24lr03719","url":null,"abstract":"","PeriodicalId":22814,"journal":{"name":"The primary care companion for CNS disorders","volume":"26 4","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-07-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141601865","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Treatment-Resistant Schizophrenia: Evaluation and Management. 耐药性精神分裂症:评估与管理》。
Q4 Medicine Pub Date : 2024-07-02 DOI: 10.4088/PCC.23f03692
Carol S Lim, Abigail L Donovan, Chirag M Vyas, Nicholas O Daneshvari, Desta S Lissanu, Theodore A Stern

The Psychiatric Consultation Service at Massachusetts General Hospital sees medical and surgical inpatients with comorbid psychiatric symptoms and conditions. During their twice-weekly rounds, Dr Stern and other members of the Consultation Service discuss diagnosis and management of hospitalized patients with complex medical or surgical problems who also demonstrate psychiatric symptoms or conditions. These discussions have given rise to rounds reports that will prove useful for clinicians practicing at the interface of medicine and psychiatry.

Prim Care Companion CNS Disord 2024;26(4):23f03692.

Author affiliations are listed at the end of this article.

马萨诸塞州综合医院的精神科会诊服务部负责诊治合并有精神症状和病症的内外科住院病人。在每周两次的查房中,斯特恩医生和会诊服务部的其他成员会讨论对有复杂内科或外科问题且同时伴有精神症状或病症的住院病人的诊断和管理。这些讨论产生的查房报告将证明对在内科和精神科交界处执业的临床医生非常有用。 作者单位列于本文末尾。
{"title":"Treatment-Resistant Schizophrenia: Evaluation and Management.","authors":"Carol S Lim, Abigail L Donovan, Chirag M Vyas, Nicholas O Daneshvari, Desta S Lissanu, Theodore A Stern","doi":"10.4088/PCC.23f03692","DOIUrl":"10.4088/PCC.23f03692","url":null,"abstract":"<p><p>The Psychiatric Consultation Service at Massachusetts General Hospital sees medical and surgical inpatients with comorbid psychiatric symptoms and conditions. During their twice-weekly rounds, Dr Stern and other members of the Consultation Service discuss diagnosis and management of hospitalized patients with complex medical or surgical problems who also demonstrate psychiatric symptoms or conditions. These discussions have given rise to rounds reports that will prove useful for clinicians practicing at the interface of medicine and psychiatry.</p><p><p><i>Prim Care Companion CNS Disord 2024;26(4):23f03692</i>.</p><p><p>\u0000 <i>Author affiliations are listed at the end of this article.</i>\u0000 </p>","PeriodicalId":22814,"journal":{"name":"The primary care companion for CNS disorders","volume":"26 4","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-07-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141601866","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Rare Case of Phentermine-Related Tardive Dyskinesia. 一个罕见的芬特明相关迟发性运动障碍病例
Q4 Medicine Pub Date : 2024-06-27 DOI: 10.4088/PCC.24cr03710
Pooja Prasad, Melanie N Corsten, Shady S Shebak, Youssef Makki
{"title":"A Rare Case of Phentermine-Related Tardive Dyskinesia.","authors":"Pooja Prasad, Melanie N Corsten, Shady S Shebak, Youssef Makki","doi":"10.4088/PCC.24cr03710","DOIUrl":"10.4088/PCC.24cr03710","url":null,"abstract":"","PeriodicalId":22814,"journal":{"name":"The primary care companion for CNS disorders","volume":"26 3","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-06-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141493500","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A 3-Times-Daily Dosing Scheme of Prazosin to Treat Posttraumatic Stress Disorder-Induced Psychological Distress in the Hospital. 用哌唑嗪每日三次给药方案治疗创伤后应激障碍引发的医院心理压力。
Q4 Medicine Pub Date : 2024-06-25 DOI: 10.4088/PCC.23cr03696
Kendall J Tucker, Trisha T Villanueva, Miles Fletcher, Katherine Putnam, Megan C Herink
{"title":"A 3-Times-Daily Dosing Scheme of Prazosin to Treat Posttraumatic Stress Disorder-Induced Psychological Distress in the Hospital.","authors":"Kendall J Tucker, Trisha T Villanueva, Miles Fletcher, Katherine Putnam, Megan C Herink","doi":"10.4088/PCC.23cr03696","DOIUrl":"10.4088/PCC.23cr03696","url":null,"abstract":"","PeriodicalId":22814,"journal":{"name":"The primary care companion for CNS disorders","volume":"26 3","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-06-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141493499","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
The primary care companion for CNS disorders
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1